Members of the EBM Focus editorial team at DynaMed® select their top clinical trial summaries of 2019.
EBM Focus: 2019 Year in Review
January 14, 2020
Hypertension is a common medical problem that almost all physicians must deal with, but what’s the rational blood pressure target?
What’s the Target of the New ACC/AHA Performance Measures?
January 08, 2020
A new 20-year follow-up study suggests that long-term statin therapy starting in childhood may prevent cardiovascular disease in patients with familial hypercholesterolemia.
EBM Focus: Statin’ Young– Benefit of Starting Statins in Children with Familial Hypercholesterolemia
January 07, 2020
We asked the Deputy Editors of DynaMed for their top clinical studies or stories of 2019.
Top Clinical Stories of 2019 from the DynaMed Deputy Editors
January 06, 2020
A new study fails to confirm efficacy of 17-P for prevention of preterm birth in women with prior preterm birth, but will this change standard of care?
EBM Focus: “Confirmatory Trial” Creates Uncertainty about 17-P for Prevention of Premature Birth
December 17, 2019
Read about new meta-analyses aiming to address whether consumption of red or processed meat is truly bad for cardiovascular health.
EBM Focus: Holy Cow! Reheating the Debate on Eating Red Meat
December 03, 2019
Get to know Martin (Marty) Mayer, DMSc, MS, PA-C, Clinical Evidence Synthesizer on the Innovations and Evidence-Based Medicine Development Team at EBSCO Information Services.
Meet the Innovations Team: Martin (Marty) Mayer, DMSc, MS, PA-C
November 18, 2019
Personalized risk-based colorectal cancer screening would be ideal, but we may not yet be ready for such an approach. Find out why in this EBM Focus.
EBM Focus: A Protoscopy of the New Colorectal Cancer Screening Guideline
November 14, 2019
A new study evaluates personalized stratification of the net benefit or harm of aspirin for primary prevention of cardiovascular disease (CVD).
EBM Focus: PREDICTing the Net Benefit of Aspirin for Primary Prevention
November 12, 2019
Point-of-care C-reactive protein (CRP) testing may allow for more judicious use of antibiotics in patients with an acute COPD exacerbation.
EBM Focus: CRP-guided Antibiotic Therapy for Acute Exacerbations of COPD
November 06, 2019
© 2020 EBSCO Industries, Inc. All rights reserved